Overexpression of Myc and Cyclin T1 via mRNA Therapy Improves Regeneration of Heart Tissue
The heart regenerates poorly in comparison to most other tissues in the body, scarring rather than recovering function, and this is one of the reasons why heart attacks have such poor outcomes for patients even given survival of the initial event. Researchers here demonstrate that overexpression of both Myc and cyclin T1 can be used to provoke greater regeneration following injury to heart tissue. The researchers used messenger RNA (mRNA) in order to produce transient overexpression, but development of a human therapy would likely require a better delivery system than was used in this proof of concept study.
Across regenerative tissues and species, Myc serves as a pivotal, nonredundant instructor of tissue regeneration following injury. Myc expression in differentiated tissues is stringently controlled and typically maintained at a low level. Following damage in a tissue capable of regeneration, local mitogenic stimulation leads to a transient increase in short-lived Myc protein followed by a rapid burst of proliferation. The regenerative Myc response has been observed across regenerative species and repair is attenuated if Myc activity is blocked.
The mammalian heart is characterized by low regenerative capacity. The lack of regeneration in the myocardium is a result of the low proliferative ability of adult cardiomyocytes. We have determined that ectopic expression of Myc alone cannot drive efficient cell division of cardiomyocytes, due to the low levels of P-TEFb in adult cardiomyocytes. P-TEFb is a protein complex comprising CDK9 and cyclin T1 that, following stimulation, is recruited to and phosphorylates RNA polymerase II to enable productive transcription. Cyclin T1 is the key factor controlling the P-TEFb levels in cardiomyocytes.
Combined overexpression of Myc and cyclin T1 in cardiomyocytes leads to efficient Myc-driven transcription that can drive juvenile and adult mouse cardiomyocyte proliferation in vivo, leading us to speculate whether this genetic combination could be explored for therapeutic benefits after cardiac injury. Here, using transgenic models and a mRNA therapeutic, we show that Myc and cyclin T1 require transient induction for cardiomyocyte proliferation that leads to myocardial repair and functional recovery after myocardial infarction in mice. This research provides a strategy to translate Myc-cyclin T1 coexpression for cardiac regeneration to address serious unmet needs in the treatment of cardiovascular disease.